Navigation Links
Drug dilemma confronts users of painkillers

The Food and Drug Administration announced that Vioxx - Merck's blockbuster painkiller, would include new information on its label. The FDA said that Merck can claim that Vioxx has fewer gastrointestinal complications// than one older non-steroidal anti-inflammatory drug, naproxen. But the FDA also decided that the Vioxx label must mention that it might be linked to an increased risk of heart attack or high blood pressure.

Manufacturer Merck & Company got good news, too: Vioxx can advertise that it's gentler to the stomach than an older competitor and that it relieves the pain of rheumatoid arthritis in addition to the more common osteoarthritis. Vioxx and another popular competitor, Celebrex, work differently than older, cheaper painkillers known to cause stomach ulcers.

Merck had fought for over a year to be allowed to say Vioxx is gentler to the stomach. Finally, the FDA agreed that an 8,000-patient study found Vioxx users had half the risk of ulcers as users of the older naproxen. The same study found Vioxx users had twice the risk of heart attacks or other cardiovascular side effects than naproxen patients.

Merck argued that Vioxx isn't bad, but that naproxen offered the added benefit of thinning the blood a little, which Vioxx doesn't do. Studies also show Vioxx can increase the risk of high blood pressure, and that people who use higher-than-recommended doses are more at risk for certain side effects.
'"/>




Page: 1

Related medicine news :

1. A ray of hope in Angioplasty dilemma
2. Safeguarding anti-inflammatory users from ulcers
3. Personality profiles of gamblers and substance abusers are similar
4. Women complain Viagra users want too much sex
5. Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers
6. Children Of Alcoholics Tend to Become Drug Abusers In Adulthood
7. UN Warns of HIV epidemic among Asia-Pacific drug users
8. Lack of treatment for cocaine users
9. Reinfection with Hepatitis C Stopped in drug users
10. Calcitriol [Vitamin D] with combination of painkillers for cancer treatment
11. Codeine-based painkillers to be used cautiously
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug dilemma confronts users painkillers

(Date:7/12/2014)... SATURDAY, July 12, 2014 (HealthDay News) -- If you make ... contends. In one experiment, 56 adults were led on ... an exercise walk or a scenic walk. The participants were ... it was an exercise outing ate 35 percent more chocolate ... a scenic walk. In another experiment, 46 adults were ...
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 Using ... so one of two inventors from Ashland, Va., decided ... do this. "This inspired us to conceive of our ... of the patent-pending KIDNEY KOVER, which provides an inconspicuous ... It avoids embarrassment, as well as promotes comfort and ...
(Date:7/12/2014)... 2014 “Critical Care Therapeutics in ... Late-Stage Four-Factor PCCs and Recombinant Products to Drive ... care market in the US, UK, France, Germany, ... an estimation of market size for 2013, along ... care indications that are being treated using the ...
(Date:7/12/2014)... article released by Seattle's well known plastic surgeon, Dr. Bryan ... cosmetic surgical procedures in summer months . , As ... enliven the rainy Pacific Northwest, many people are turning their ... out as much during the winter as they had planned. ... eager to look their best for their summer vacations, and ...
(Date:7/12/2014)... West Palm Beach, FL (PRWEB) July 12, 2014 ... wide variety of high-quality peptides that are used solely ... online. To honor two successful years in business, Maxim ... Performance LLC, has just launched a new and updated ... addition, the research blog section has been updated with ...
Breaking Medicine News(10 mins):Health News:Make Exercise Fun, Eat Less Afterwards 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:Best Summer Cosmetic Surgeries Revealed in Article By Seattle Plastic Surgeon 2Health News:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2
... Macmillan Cancer Support of UK has taken a strong campaign ... that in Scotland people spent// an average of ?636 on ... in Wales. ,The demand of the charity is ... ,"These regional variations are shocking and grossly unfair - cancer ...
... to heart abnormalities, is apparently safe to use in ... yesterday//. The researchers said that they found no ... their pregnancies fearing that the drug could affect their ... studied 119 women treated with Seroxat for six years ...
... suffering, a tuberculosis (TB) patient in Madhya Pradesh has requested Indian ... life and that of his four minor children. ... late 40s, is suffering from TB and has long been dependent ... of TB a few years ago. ,He has now ...
... chemical compound found in cannabis, also known as hashish ... after testing it on rats //. ,Yehoshua ... Israel, has created a synthetic version of a minor ... help in lowering blood pressure, reported science portal The ...
... a common school system in the country, educationists Sunday ... primary education //system and remove disparities among students. ... system in the country so that all students get ... said Madhu Prasad, educationist and a professor in Delhi ...
... Administration borrowed data from the 2004 National Survey on ... persons, 12 years of age or older, made ... to the survey. Meanwhile, an estimated 2.1 million Americans ... cocaine abuse. ,The statistics revealed the following ...
Cached Medicine News:
(Date:7/10/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... sale to Galderma of all rights to Restylane, Perlane, ... for $1.4 billion in cash, pursuant to the previously ... acquisition of Galderma. "We are pleased ... company that is firmly committed to the aesthetic dermatology ...
(Date:7/10/2014)... BURLINGTON, Mass. , July 10, 2014 /PRNewswire/ ... three-quarters of surveyed infectious disease (ID) specialists are ... Medicines Company,s Orbactiv (oritavancin) for use as OPAT, ... to prescribe these agents to their hospital inpatients. ... percent) of OPAT patients are initiated on OPAT ...
(Date:7/10/2014)... 10, 2014 CVS Caremark Corporation (NYSE: ... approved a quarterly dividend of $0.275 (27.5 cents) per share ... August 1, 2014, to holders of record on July 21, ... Caremark is dedicated to helping people on their path to ... the United States . Through the company,s more ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 20, 2012  NxStage Medical, Inc. (Nasdaq: NXTM ... announced plans to release its financial results for the ... on Wednesday, February 29, 2012  before the opening of ... ) NxStage will also host a conference ...
... 2012  INVO Bioscience, Inc. (OTC BB: IVOB), a medical ... with infertility, today announced that the National Health Surveillance ... INVOcell for use as a Class II device. This ... of infertile couples in Brazil and marks a major ...
Cached Medicine Technology:NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 3
... eliminate false signals and contamination caused ... Promega Barrier Tips offer performance and ... acids (PCR(a)), radioactive isotopes, tissue culture ... specimens. , ,Promega Barrier Tips are ...
... tips eliminate false signals and contamination ... tested, Promega Barrier Tips offer performance ... nucleic acids (PCR(a)), radioactive isotopes, tissue ... serological specimens. , ,Promega Barrier Tips ...
... AvantGard Low Binding 0.5l - 10l Eppendorf ... binding technology that significantly reduces the amount of ... other filter tips are advertised as low retention, ... adhering to the pipet tip. However, AvantGard also ...
10 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 2, 5 and 10 L pipettes....
Medicine Products: